Novel siRNA delivery system to target podocytes in vivo

Peter V. Hauser, Jeffrey W. Pippin, Cora Kaiser, Ronald D. Krofft, Paul T. Brinkkoetter, Kelly L. Hudkins, Dontscho Kerjaschki, Jochen Reiser, Charles E. Alpers, Stuart J. Shankland

Research output: Contribution to journalArticlepeer-review

53 Scopus citations


Podocytes are injured in several glomerular diseases. To alter gene expression specifically in podocytes in vivo, we took advantage of their active endocytotic machinery and developed a method for the targeted delivery of small interfering ribonucleic acids (siRNA). We generated an anti-mouse podocyte antibody that binds to rat and mouse podocytes in vivo. The polyclonal IgG antibody was cleaved into monovalent fragments, while preserving the antigen recognition sites. One Neutravidin molecule was linked to each monovalent IgG via the available sulfohydryl group. Protamine, a polycationic nuclear protein and universal adaptor for anionic siRNA, was linked to the neutravidin via biotin. The delivery system was named shamporter ( sheep anti mouse podocyte trans porter). Injection of shamporter coupled with either nephrin siRNA or TRPC6 siRNA via tail vein into normal rats substantially reduced the protein levels of nephrin or TRPC6 respectively, measured by western blot analysis and immunostaining. The effect was target specific because other podocyte-specific genes remained unchanged. Shamporter + nephrin siRNA induced transient proteinuria in rats. Control rats injected with shamporter coupled to control-siRNA showed no changes. These results show for the first time that siRNA can be delivered efficiently and specifically to podocytes in vivo using an antibody-delivery system.

Original languageEnglish (US)
Article numbere9463
JournalPloS one
Issue number3
StatePublished - Mar 1 2010
Externally publishedYes

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Novel siRNA delivery system to target podocytes in vivo'. Together they form a unique fingerprint.

Cite this